LNSR Price / Book | LENSAR, INC.

LENSAR, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

LENSAR, Inc. price/book ratio for the quarter ending 2026-06-30 was 4.71, a change of 11.52 year-over-year.
LENSAR, Inc. price/book ratio for the quarter ending 2026-03-31 was 6.71, a change of 14.23 year-over-year.
LENSAR, Inc. price/book ratio for the quarter ending 2025-12-31 was -5.35, a 124.95% decline year-over-year.
LENSAR, Inc. price/book ratio for the quarter ending 2025-09-30 was -5.69, a 343.25% decline year-over-year.
LENSAR, Inc. price/book ratio for fiscal 2026 was 4.71.
LENSAR, Inc. price/book ratio for fiscal 2025 was -5.35, a 124.95% decline from fiscal 2024.
LENSAR, Inc. price/book ratio for fiscal 2024 was 21.43, a 1701.77% increase from fiscal 2023.
LENSAR, Inc. price/book ratio for fiscal 2023 was 1.19, a 52.07% increase from fiscal 2022.

Available history: 2020-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	4.71	$70.25M	$14.91M
2026-03-31	6.71	$72.36M	$10.79M
2025-12-31	-5.35	$139.12M	-$26.02M
2025-09-30	-5.69	$147.4M	-$25.91M
2025-06-30	-6.81	$156.98M	-$23.05M
2025-03-31	-7.52	$166.47M	-$22.14M
2024-12-31	21.43	$104.19M	$4.86M
2024-09-30	2.34	$53.18M	$22.74M
2024-06-30	2.2	$51.95M	$23.65M
2024-03-31	1.22	$38.71M	$31.84M
2023-12-31	1.19	$39.76M	$33.43M
2023-09-30	0.96	$34.75M	$36.38M
2023-06-30	1.46	$47.6M	$32.69M
2023-03-31	0.7	$27.65M	$39.44M
2022-12-31	0.78	$32.84M	$41.98M
2022-09-30	1.44	$61.18M	$42.58M
2022-06-30	1.6	$71.75M	$44.9M
2022-03-31	1.63	$81.29M	$49.81M
2021-12-31	1.2	$65.83M	$54.88M
2021-09-30	1.47	$83.82M	$57.05M
2021-06-30	1.54	$94.89M	$61.63M
2021-03-31	1.23	$79.37M	$64.33M
2020-12-31	1.18	$79.26M	$67.21M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	4.71	$70.25M	$14.91M
2025-12-31	-5.35	$139.12M	-$26.02M
2024-12-31	21.43	$104.19M	$4.86M
2023-12-31	1.19	$39.76M	$33.43M
2022-12-31	0.78	$32.84M	$41.98M
2021-12-31	1.2	$65.83M	$54.88M
2020-12-31	1.18	$79.26M	$67.21M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
SkinHealth Systems Inc. (SKIN)	United States	$0.086B	-3.17
Microbot Medical Inc. (MBOT)		$0.089B	-7.97
Pulmonx Corp (LUNG)	United States	$0.082B	-1.16
RenovoRx, Inc. (RNXT)	United States	$0.076B	-3.62
FRACTYL HEALTH, INC. (GUTS)	United States	$0.075B	-1.18
CVRx, Inc. (CVRX)	United States	$0.067B	-2.62
DarioHealth Corp. (DRIO)		$0.066B	-1.39
TELA Bio, Inc. (TELA)	United States	$0.057B	-0.82
Apyx Medical Corp (APYX)	United States	$0.120B	-21.85
Xtant Medical Holdings, Inc. (XTNT)	United States	$0.053B